Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4

Ravshan Burikhanov, Tripti Shrestha-Bhattarai, Shirley Qiu, Nidhi Shukla, Nikhil Hebbar, Subodh M Lele, Craig Horbinski, Vivek M. Rangnekar

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Tumor suppressor PAR-4 acts in part by modulating sensitivity to apoptosis, but the basis for its activity is not fully understood. In this study, we describe a novel mechanism of antiapoptosis by NF-κB, revealing that it can block PAR-4-mediated apoptosis by downregulating trafficking of the PAR-4 receptor GRP78 from the endoplasmic reticulum to the cell surface. Mechanistic investigations revealed that NF-κB mediated this antiapoptotic mechanism by upregulating expression of UACA, a proinflammatory protein in certain disease settings. In clinical specimens of cancer, a strong correlation existed between NF-κB activity and UACA expression, relative to normal tissues. UACA bound to intracellular PAR-4 in diverse cancer cells, where it prevented translocation of GRP78 from the endoplasmic reticulum to the cell surface. This pathway of antiapoptosis could be inhibited by suppressing levels of NF-κB or UACA expression, which enhanced endoplasmic reticulum stress and restored GRP78 trafficking to the cell surface, thereby sensitizing cancer cells to apoptosis by extracellular PAR-4 or GRP78 agonistic antibody. In summary, our results identify a novel intracellular pathway of apoptosis mediated by NF-κB through UACA elevation, which by attenuating endoplasmic reticulum stress and GRP78 translocation to the cell surface can blunt the sensitivity of cancer cells to apoptosis.

Original languageEnglish (US)
Pages (from-to)1011-1019
Number of pages9
JournalCancer Research
Volume73
Issue number2
DOIs
StatePublished - Jan 15 2013

Fingerprint

Apoptosis
Neoplasms
Endoplasmic Reticulum Stress
Endoplasmic Reticulum
Down-Regulation
Antibodies
Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Burikhanov, R., Shrestha-Bhattarai, T., Qiu, S., Shukla, N., Hebbar, N., Lele, S. M., ... Rangnekar, V. M. (2013). Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4. Cancer Research, 73(2), 1011-1019. https://doi.org/10.1158/0008-5472.CAN-12-3212

Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4. / Burikhanov, Ravshan; Shrestha-Bhattarai, Tripti; Qiu, Shirley; Shukla, Nidhi; Hebbar, Nikhil; Lele, Subodh M; Horbinski, Craig; Rangnekar, Vivek M.

In: Cancer Research, Vol. 73, No. 2, 15.01.2013, p. 1011-1019.

Research output: Contribution to journalArticle

Burikhanov, R, Shrestha-Bhattarai, T, Qiu, S, Shukla, N, Hebbar, N, Lele, SM, Horbinski, C & Rangnekar, VM 2013, 'Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4', Cancer Research, vol. 73, no. 2, pp. 1011-1019. https://doi.org/10.1158/0008-5472.CAN-12-3212
Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM et al. Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4. Cancer Research. 2013 Jan 15;73(2):1011-1019. https://doi.org/10.1158/0008-5472.CAN-12-3212
Burikhanov, Ravshan ; Shrestha-Bhattarai, Tripti ; Qiu, Shirley ; Shukla, Nidhi ; Hebbar, Nikhil ; Lele, Subodh M ; Horbinski, Craig ; Rangnekar, Vivek M. / Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4. In: Cancer Research. 2013 ; Vol. 73, No. 2. pp. 1011-1019.
@article{805ff84ddcde422d83991ad51f16fdb3,
title = "Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4",
abstract = "Tumor suppressor PAR-4 acts in part by modulating sensitivity to apoptosis, but the basis for its activity is not fully understood. In this study, we describe a novel mechanism of antiapoptosis by NF-κB, revealing that it can block PAR-4-mediated apoptosis by downregulating trafficking of the PAR-4 receptor GRP78 from the endoplasmic reticulum to the cell surface. Mechanistic investigations revealed that NF-κB mediated this antiapoptotic mechanism by upregulating expression of UACA, a proinflammatory protein in certain disease settings. In clinical specimens of cancer, a strong correlation existed between NF-κB activity and UACA expression, relative to normal tissues. UACA bound to intracellular PAR-4 in diverse cancer cells, where it prevented translocation of GRP78 from the endoplasmic reticulum to the cell surface. This pathway of antiapoptosis could be inhibited by suppressing levels of NF-κB or UACA expression, which enhanced endoplasmic reticulum stress and restored GRP78 trafficking to the cell surface, thereby sensitizing cancer cells to apoptosis by extracellular PAR-4 or GRP78 agonistic antibody. In summary, our results identify a novel intracellular pathway of apoptosis mediated by NF-κB through UACA elevation, which by attenuating endoplasmic reticulum stress and GRP78 translocation to the cell surface can blunt the sensitivity of cancer cells to apoptosis.",
author = "Ravshan Burikhanov and Tripti Shrestha-Bhattarai and Shirley Qiu and Nidhi Shukla and Nikhil Hebbar and Lele, {Subodh M} and Craig Horbinski and Rangnekar, {Vivek M.}",
year = "2013",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-12-3212",
language = "English (US)",
volume = "73",
pages = "1011--1019",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4

AU - Burikhanov, Ravshan

AU - Shrestha-Bhattarai, Tripti

AU - Qiu, Shirley

AU - Shukla, Nidhi

AU - Hebbar, Nikhil

AU - Lele, Subodh M

AU - Horbinski, Craig

AU - Rangnekar, Vivek M.

PY - 2013/1/15

Y1 - 2013/1/15

N2 - Tumor suppressor PAR-4 acts in part by modulating sensitivity to apoptosis, but the basis for its activity is not fully understood. In this study, we describe a novel mechanism of antiapoptosis by NF-κB, revealing that it can block PAR-4-mediated apoptosis by downregulating trafficking of the PAR-4 receptor GRP78 from the endoplasmic reticulum to the cell surface. Mechanistic investigations revealed that NF-κB mediated this antiapoptotic mechanism by upregulating expression of UACA, a proinflammatory protein in certain disease settings. In clinical specimens of cancer, a strong correlation existed between NF-κB activity and UACA expression, relative to normal tissues. UACA bound to intracellular PAR-4 in diverse cancer cells, where it prevented translocation of GRP78 from the endoplasmic reticulum to the cell surface. This pathway of antiapoptosis could be inhibited by suppressing levels of NF-κB or UACA expression, which enhanced endoplasmic reticulum stress and restored GRP78 trafficking to the cell surface, thereby sensitizing cancer cells to apoptosis by extracellular PAR-4 or GRP78 agonistic antibody. In summary, our results identify a novel intracellular pathway of apoptosis mediated by NF-κB through UACA elevation, which by attenuating endoplasmic reticulum stress and GRP78 translocation to the cell surface can blunt the sensitivity of cancer cells to apoptosis.

AB - Tumor suppressor PAR-4 acts in part by modulating sensitivity to apoptosis, but the basis for its activity is not fully understood. In this study, we describe a novel mechanism of antiapoptosis by NF-κB, revealing that it can block PAR-4-mediated apoptosis by downregulating trafficking of the PAR-4 receptor GRP78 from the endoplasmic reticulum to the cell surface. Mechanistic investigations revealed that NF-κB mediated this antiapoptotic mechanism by upregulating expression of UACA, a proinflammatory protein in certain disease settings. In clinical specimens of cancer, a strong correlation existed between NF-κB activity and UACA expression, relative to normal tissues. UACA bound to intracellular PAR-4 in diverse cancer cells, where it prevented translocation of GRP78 from the endoplasmic reticulum to the cell surface. This pathway of antiapoptosis could be inhibited by suppressing levels of NF-κB or UACA expression, which enhanced endoplasmic reticulum stress and restored GRP78 trafficking to the cell surface, thereby sensitizing cancer cells to apoptosis by extracellular PAR-4 or GRP78 agonistic antibody. In summary, our results identify a novel intracellular pathway of apoptosis mediated by NF-κB through UACA elevation, which by attenuating endoplasmic reticulum stress and GRP78 translocation to the cell surface can blunt the sensitivity of cancer cells to apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=84872509120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872509120&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-3212

DO - 10.1158/0008-5472.CAN-12-3212

M3 - Article

VL - 73

SP - 1011

EP - 1019

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -